Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Nov 23;24(12):1569-1582.
doi: 10.1093/ehjci/jead169.

Lung ultrasound in acute and chronic heart failure: a clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI)

Luna Gargani  1 , Nicolas Girerd  2 , Elke Platz  3 , Pierpaolo Pellicori  4 , Ivan Stankovic  5 , Alberto Palazzuoli  6 , Emanuele Pivetta  7   8 , Marcelo Haertel Miglioranza  9   10 , Hatem Soliman-Aboumarie  11   12 , Eustachio Agricola  13 , Giovanni Volpicelli  14 , Susanna Price  15 , Erwan Donal  16 , Bernard Cosyns  17 , Aleksandar N Neskovic  5 ; This document was reviewed by members of the 2020–2022 EACVI Scientific Documents Committee
Collaborators, Affiliations

Lung ultrasound in acute and chronic heart failure: a clinical consensus statement of the European Association of Cardiovascular Imaging (EACVI)

Luna Gargani et al. Eur Heart J Cardiovasc Imaging. .
No abstract available

Keywords: B-lines; acute dyspnoea; acute heart failure; chest sonography; chronic heart failure; heart failure; lung ultrasound; point-of-care ultrasound.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Dr. Gargani: no conflict of interest related to this paper. Outside of this paper, Dr. Gargani has received consultancy honoraria from Philips Helathcare, GE Healthcare, Caption Health, EchoNous. Dr. Girerd: no conflict of interest related to this paper. Outside of this paper, Dr. Girerd has received consultancy honoraria from Astra Zeneca, Bayer, Boehringer-Ingelheim, Novartis, Lilly, Vifor International. Dr. Platz: no conflict of interest related to this paper. Outside of this paper, Dr. Platz’ employer has received support from Novartis for consulting work, and she has consulted for scPharmaceuticals. She has received research support from the NIH (R01HL148439), the American Heart Association and AstraZeneca. Dr. Pellicori: no conflict of interest related to this paper. Outside of this paper, Dr. Pellicori has received consultancy honoraria and/or sponsorship support from Boehringer Ingelheim, Pharmacosmos, Novartis, Vifor, AstraZeneca and Caption Health, and researchsupport from Bristol Myers Squibb. Dr. Stankovic: no conflict of interest related to this paper. Outside of this paper, Dr. Stankovic has received consultancy honoraria from Servier, Boehringer-Ingelheim, Pfizer, Astra Zeneca, Novartis, Merck Sharp & Dohme. Dr. Palazzuoli: no conflict of interest to declare. Dr. Pivetta: no conflict of interest related to this paper. Outside of this paper, Dr. Pivetta has received research support from Butterfly inc. Dr. Miglioranza: no conflict of interest related to this paper. Outside of this paper, Dr. Miglioranza has received consultancy honoraria from Philips, GE Healthcare, Abbott. Dr. Aboumarie: no conflict of interest to declare. Dr. Agricola: no conflict of interest related to this paper. Outside of this paper, Dr. Agricola has received consultancy honoraria from Philips, Edwards Lifesciences. Dr. Volpicelli: no conflict of interest to declare. Dr. Price: no conflict of interest to declare. Dr. Donal: no conflict of interest related to this paper. Outside of this paper, Dr. Donal has received research funding from Abbott. Dr. Cosyns: no conflict of interest related to this paper. Outside of this paper, Dr. Cosyns has received research funding from Abbott. Dr. Neskovic: no conflict of interest related to this paper. Outside of this paper, Dr. Neskovic has received consultancy honoraria from Bayer, AstraZeneca, Pfizer, Boehringer Ingelheim, Servier and Novartis.

Figures

Figure 1
Figure 1
The sonographic pattern of a normally aerated lung with the pleural line (upper dotted yellow line) and A-lines (lower dotted orange lines).
Figure 2
Figure 2
B-lines indicated by dotted white lines.
Figure 3
Figure 3
The left costophrenic angle with pleural effusion.
Figure 4
Figure 4
Pleural effusion with compression atelectasis.
Figure 5
Figure 5
Different patterns of consolidation at LUS: A) pneumonia; B) pulmonary infarction; C) compression atelectasis; D) obstructive atelectasis.
Figure 6
Figure 6
Different LUS scanning protocols, ranging from 4 to 28 zones; the imaging protocol should be performed on both hemithoraces (in the 28-zone protocol, the left hemithorax does not include the fifth intercostal space).
Figure 7
Figure 7
How to quantify B-lines.
Figure 8
Figure 8
Integrated cardiopulmonary ultrasound for the differential diagnosis of respiratory and circulatory failure.
See this image and copyright information in PMC

References

    1. Lichtenstein D, Mezière G. A lung ultrasound sign allowing bedside distinction between pulmonary edema and COPD: the comet-tail artifact. Intensive Care Med 1998;24:1331–4. - PubMed
    1. Lichtenstein DA, Mezière GA. Relevance of lung ultrasound in the diagnosis of acute respiratory failure: the BLUE protocol. Chest 2008;134:117–25. - PMC - PubMed
    1. Picano E, Frassi F, Agricola E, Gligorova S, Gargani L, Mottola G. Ultrasound lung comets: a clinically useful sign of extravascular lung water. J Am Soc Echocardiogr 2006;19:356–63 - PubMed
    1. Gargani L. Ultrasound of the lungs: more than a room with a view. Heart Fail Clin 2019;15:297–303. - PubMed
    1. Gargani L. Lung ultrasound: a new tool for the cardiologist. Cardiovasc Ultrasound 2011;9:6. - PMC - PubMed

Publication types